This episode examines the pharmacologic basis of GLP-1 adverse reactions, dose titration strategies, and patient-specific factors shaping therapy safety.
Nicole Snow
Advertisement
Nicole Snow joined the Olympia family in April 2022 as the pharmacist in charge of our 503A compounding pharmacy. Nicole began her journey in pharmacy in the home infusion and specialty pharmacy area. Following her graduation from University of Missouri – KC, Nicole moved to Florida in 2014 as a compounding pharmacist for Florida Hospital Home Infusion.
Since her time at Olympia Pharmaceuticals, Nicole has expanded her PIC role into Director of Pharmacy and then over to the clinical department and currently leads our clinical pharmacist team. During her time at Olympia Pharmaceuticals, Nicole has gained several additional state licenses as well as become a Board Certified Sterile Compounding Pharmacist.
During her free time, Nicole spends time with her young daughter, husband and yellow lab in the outdoors, and exploring central Florida’s activities.
Articles by Nicole Snow
In the second episode of our GLP-1 Therapy Insights series, experts Judith Hey-Hadavi from Worldwide Clinical Trials and Nicole Snow from Olympia Pharmaceuticals discuss the evolution of GLP-1 receptor agonists from protein-based therapies to small-molecule options.
Explore GLP-1 receptor agonists with experts Judith Heij-Hadavi and Nicole Snow: molecular design, patient care, oral therapies, and analytical insights.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
